Trials / Conditions / Restless Legs Syndrome (RLS)

Restless Legs Syndrome (RLS)

14 registered clinical trials studyying Restless Legs Syndrome (RLS) — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Study on the Mechanism of Gut Microbiota Mediating Restless Legs Syndrome Through Iron Metabolism NCT07307482	Wenxia Jiang	—
Terminated	Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia NCT02826681	American Regent, Inc.	Phase 2
Completed	A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients NCT03053427	Astellas Pharma Inc	Phase 4
Completed	Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS NCT02397057	American Regent, Inc.	Phase 3
Completed	Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients Wi NCT01981941	Astellas Pharma Inc	Phase 4
Completed	Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome NCT01823770	University Hospital, Montpellier	Phase 4
Completed	Efficacy of Tyrosine in Restless Legs Syndrome NCT01494766	Seton Healthcare Family	N/A
Completed	Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects NCT01411124	XenoPort, Inc.	Phase 1
Completed	Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Distur NCT00748098	XenoPort, Inc.	Phase 3
Completed	12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome NCT00373542	GlaxoSmithKline	Phase 4
Completed	Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS) NCT01382901	American Regent, Inc.	Phase 2
Completed	RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole NCT00314860	GlaxoSmithKline	Phase 3
Completed	Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Synd NCT00256854	GlaxoSmithKline	Phase 3
Completed	A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome NCT00363857	GlaxoSmithKline	Phase 3